These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation. Meduru H, Wang YT, Tsai JJ, Chen YC. Int J Mol Sci; 2016 Jun 13; 17(6):. PubMed ID: 27304951 [Abstract] [Full Text] [Related]
30. Synthesis, biological assay in vitro and molecular docking studies of new imidazopyrazinone derivatives as potential dipeptidyl peptidase IV inhibitors. Zhu Y, Xia S, Zhu M, Yi W, Cheng J, Song G, Li Z, Lu P. Eur J Med Chem; 2010 Nov 13; 45(11):4953-62. PubMed ID: 20800322 [Abstract] [Full Text] [Related]
32. Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation. Xing J, Li Q, Zhang S, Liu H, Zhao L, Cheng H, Zhang Y, Zhou J, Zhang H. Chem Biol Drug Des; 2014 Sep 13; 84(3):364-77. PubMed ID: 24674599 [Abstract] [Full Text] [Related]
33. Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4). Pantaleão SQ, Philot EA, de Oliveira Almeida M, Lima AN, de Sairre MI, Scott AL, Honorio KM. Curr Top Med Chem; 2020 Sep 13; 20(3):209-226. PubMed ID: 31878857 [Abstract] [Full Text] [Related]